{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:24:51Z","timestamp":1723163091977},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,8]]},"DOI":"10.7759\/cureus.66469","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:17:07Z","timestamp":1723155427000},"source":"Crossref","is-referenced-by-count":0,"title":["It\u2019s Not Always Infections When It Comes to Resource-Poor Countries: A Fascinating Case Report"],"prefix":"10.7759","author":[{"given":"Gowri","family":"Swaminathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshia","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santino","family":"Patrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Elhawary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuha","family":"Al-Howthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utsow","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celeste","family":"Defillo-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.09.031","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two?","volume":"80","author":"van Munster KN","year":"2024","unstructured":"van Munster KN, Bergquist A, Ponsioen CY. Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two?. J Hepatol. 2024, 80:155-68. 10.1016\/j.jhep.2023.09.031","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01042-9","article-title":"Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis","volume":"55","author":"Kim YS","year":"2023","unstructured":"Kim YS, Hurley EH, Park Y, Ko S. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis. Exp Mol Med. 2023, 55:1380-7. 10.1038\/s12276-023-01042-9","journal-title":"Exp Mol Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastre.2019.02.030","article-title":"Primary sclerosing cholangitis and inflammatory bowel disease: intestine-liver correlation [Article in Spanish]","volume":"42","author":"N\u00fa\u00f1ez P","year":"2019","unstructured":"N\u00fa\u00f1ez P, Quera R, Gomoll\u00f3n F. Primary sclerosing cholangitis and inflammatory bowel disease: intestine-liver correlation [Article in Spanish]. Gastroenterolog\u00eda y Hepatolog\u00eda. 2019, 42:316-25. 10.1016\/j.gastre.2019.02.030","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000573","article-title":"Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study","volume":"8","author":"Irving PM","year":"2021","unstructured":"Irving PM, de Lusignan S, Tang D, Nijher M, Barrett K. Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study. BMJ Open Gastroenterol. 2021, 8:10.1136\/bmjgast-2020-000573","journal-title":"BMJ Open Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier JF","year":"2014","unstructured":"Rahier JF, Magro F, Abreu C, et al.. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014, 8:443-68. 10.1016\/j.crohns.2013.12.013","journal-title":"J Crohns Colitis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.02.015","article-title":"Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases","volume":"7","author":"Ananthakrishnan AN","year":"2013","unstructured":"Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013, 7:107-12. 10.1016\/j.crohns.2012.02.015","journal-title":"J Crohns Colitis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000178149.36881.df","article-title":"The deafness of Ludwig van Beethoven: an immunopathy","volume":"26","author":"Karmody CS","year":"2005","unstructured":"Karmody CS, Bachor ES. The deafness of Ludwig van Beethoven: an immunopathy. Otol Neurotol. 2005, 26:809-14. 10.1097\/01.mao.0000178149.36881.df","journal-title":"Otol Neurotol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra K","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ, et al.. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013, 58:2045-55. 10.1002\/hep.26565","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen N","year":"2020","unstructured":"Barner-Rasmussen N, Pukkala E, Jussila A, F\u00e4rkkil\u00e4 M. Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland. Scand J Gastroenterol. 2020, 55:74-81. 10.1080\/00365521.2019.1707277","journal-title":"Scand J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.08.039","article-title":"Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies","volume":"20","author":"Trivedi PJ","year":"2022","unstructured":"Trivedi PJ, Bowlus CL, Yimam KK, Razavi H, Estes C. Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies. Clin Gastroenterol Hepatol. 2022, 20:1687-1700.e4. 10.1016\/j.cgh.2021.08.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist B","year":"2010","unstructured":"Lindkvist B, Benito de Valle M, Gullberg B, Bj\u00f6rnsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010, 52:571-7. 10.1002\/hep.23678","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01726.x","article-title":"Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis","volume":"28","author":"Tanaka A","year":"2008","unstructured":"Tanaka A, Takamori Y, Toda G, Ohnishi S, Takikawa H. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Liver Int. 2008, 28:983-9. 10.1111\/j.1478-3231.2008.01726.x","journal-title":"Liver Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng SC","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, et al.. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017, 390:2769-78. 10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype are associated with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller TJ","year":"2017","unstructured":"Weism\u00fcller TJ, Trivedi PJ, Bergquist A, et al.. Patient age, sex, and inflammatory bowel disease phenotype are associated with course of primary sclerosing cholangitis. Gastroenterology. 2017, 152:1975-1984.e8. 10.1053\/j.gastro.2017.02.038","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra K","year":"2012","unstructured":"Boonstra K, van Erpecum KJ, van Nieuwkerk KM, et al.. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis. 2012, 18:2270-6. 10.1002\/ibd.22938","journal-title":"Inflamm Bowel Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000660","article-title":"Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands","volume":"28","author":"de Groof EJ","year":"2016","unstructured":"de Groof EJ, Rossen NG, van Rhijn BD, et al.. Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands. Eur J Gastroenterol Hepatol. 2016, 28:1065-72. 10.1097\/MEG.0000000000000660","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13548","article-title":"Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977-2011","volume":"38","author":"S\u00f8rensen J\u00d8","year":"2018","unstructured":"S\u00f8rensen J\u00d8, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, B\u00e9lard E, Jess T. Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977-2011. Liver Int. 2018, 38:532-41. 10.1111\/liv.13548","journal-title":"Liver Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"J\u00f8rgensen KK","year":"2012","unstructured":"J\u00f8rgensen KK, Grzyb K, Lundin KE, et al.. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients. Inflamm Bowel Dis. 2012, 18:536-45. 10.1002\/ibd.21699","journal-title":"Inflamm Bowel Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748%2Fwjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries AB","year":"2015","unstructured":"de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol. 2015, 21:1956-71. 10.3748%2Fwjg.v21.i6.1956","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto A","year":"2018","unstructured":"Ricciuto A, Kamath BM, Griffiths AM. The IBD and PSC phenotypes of PSC-IBD. Curr Gastroenterol Rep. 2018, 20:16. 10.1007\/s11894-018-0620-2","journal-title":"Curr Gastroenterol Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz209","article-title":"Unique phenotypic characteristics and clinical course in patients with ulcerative colitis and primary sclerosing cholangitis: a multicenter US experience","volume":"26","author":"Wang MH","year":"2020","unstructured":"Wang MH, Mousa OY, Friton JJ, et al.. Unique phenotypic characteristics and clinical course in patients with ulcerative colitis and primary sclerosing cholangitis: a multicenter US experience. Inflamm Bowel Dis. 2020, 26:774-9. 10.1093\/ibd\/izz209","journal-title":"Inflamm Bowel Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000176435.19197.88","article-title":"Pathologic features and clinical significance of \"backwash\" ileitis in ulcerative colitis","volume":"29","author":"Haskell H","year":"2005","unstructured":"Haskell H, Andrews CW Jr, Reddy SI, et al.. Pathologic features and clinical significance of \"backwash\" ileitis in ulcerative colitis. Am J Surg Pathol. 2005, 29:1472-81. 10.1097\/01.pas.0000176435.19197.88","journal-title":"Am J Surg Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.064","article-title":"Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease","volume":"136","author":"S\u00f6derlund S","year":"2009","unstructured":"S\u00f6derlund S, Brandt L, Lapidus A, et al.. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009, 136:1561-7; quiz 1818-9. 10.1053\/j.gastro.2009.01.064","journal-title":"Gastroenterology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter M","year":"2004","unstructured":"Rutter M, Saunders B, Wilkinson K, et al.. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004, 126:451-9. 10.1053\/j.gastro.2003.11.010","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3748%2Fwjg.v26.i23.3126","article-title":"Review of primary sclerosing cholangitis with increased IgG4 levels","volume":"26","author":"Manganis CD","year":"2020","unstructured":"Manganis CD, Chapman RW, Culver EL. Review of primary sclerosing cholangitis with increased IgG4 levels. World J Gastroenterol. 2020, 26:10.3748%2Fwjg.v26.i23.3126","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes FD","year":"2006","unstructured":"Mendes FD, Jorgensen R, Keach J, et al.. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2006, 101:","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/281321-its-not-always-infections-when-it-comes-to-resource-poor-countries-a-fascinating-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:17:13Z","timestamp":1723155433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/281321-its-not-always-infections-when-it-comes-to-resource-poor-countries-a-fascinating-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.66469","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}